glp-1 obesity drug news The revolution: What UAB researchers are discovering about how these drugs work FAQ of the Month: Is
Description
Contract Manufacturing and CDMO Strategies Pharmaceutical companies are not relying solely on in-house capacity expansion
venous sinus stenting for idiopathic intracranial hypertension (IIH)] [7], and novel therapeutics (i.e
The information contained in this article is not intended to treat, diagnose or replace the advice of a health practitioner
doi: 10.1056/NEJMoa1307684
In a cohort study of individuals with T2D and metabolic-associated fatty liver cirrhosis (459 GLP-1RA users), GLP-1RA therapy was associated with reduced risks of hepatic decompensation, portal hypertension, hepatocellular carcinoma, and liver transplantation (111)
Thomas MK, Nikooienejad A, Bray R, Cui X, Wilson J, Duffin K, Milicevic Z, Haupt A, Robins DA
